𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones

✍ Scribed by J Shoda; T Ueda; T Ikegami; Y Matsuzaki; S Satoh; M Kano; K Matsuura; N Tanaka

Book ID
119755705
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
477 KB
Volume
112
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Effects of long-term ursodeoxycholate ad
Effects of long-term ursodeoxycholate administration on expression levels of secretory low–molecular-weight phospholipases A and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones
✍ Masahito Kano; Junichi Shoda; Tatsuro Irimura; Tetsuya Ueda; Ryu Iwasaki; Tetsuy πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 444 KB

Group IIA phospholipase A2 (PLA2), a secretory low-molecular-weight PLA2, may play a critical role in the process of gallbladder mucosal inflammation in multiple cholesterol stones, which in turn may produce biliary pronucleating proteins as well as mucin. On the other hand, ursodeoxycholate (UDC) d

Group II phospholipase A2 is increased i
Group II phospholipase A2 is increased in peritoneal and pleural effusions in patients with various types of cancer
✍ Toshihiko Abe; Kiyoshi Sakamoto; Hidenobu Kamohara; Yu-ichi Hirano; Nobuhiro Kuw πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 127 KB πŸ‘ 2 views

Serum levels of group II phospholipase A2 (PLA2) have been reported to be associated with stage of disease in cancer patients. These levels are also related to the malignant potential in tissues, and are an important prognostic factor. We radioimmunoassayed group II PLA2 levels in pleural and perito